Syantra Emerges from Stealth with AI Powered RNA-Based Immune Response Detection Liquid Biopsy Platform

Blood test for prostate cancer could help avoid unnecessary biopsies.

Labour Market Information Study

Future Fields Announces New Paradigm in CDMO Services Optimized for Small-to-Medium-Sized Biopharma Companies

Edmonton Global and Applied Pharmaceutical Innovation Join Forces to Accelerate Growth in Life Sciences Sector

Strong growth in both Human Pharma and Animal Health expanding across key therapy areas

KASTx Life Sciences Fund I Closes First Funding Round

Syantra Receives CE Mark Approval for their Breast Cancer Test Built on the Syantra DX™ Liquid Biopsy Platform

GlycoNet and partners invest $1.7M in Canadian-led health research and bioinnovation

Canada needs to invest now to address antimicrobial resistance